MyMD Pharmaceuticals MYMD Stock
MyMD Pharmaceuticals Price Chart
MyMD Pharmaceuticals MYMD Financial and Trading Overview
| MyMD Pharmaceuticals stock price | 2.4 USD |
| Previous Close | 1.55 USD |
| Open | 1.55 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 1200 |
| Day's Range | 1.53 - 1.64 USD |
| 52 Week Range | 0.9 - 6.15 USD |
| Volume | 229.87K USD |
| Avg. Volume | 533.78K USD |
| Market Cap | 64.95M USD |
| Beta (5Y Monthly) | 4.470652 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MYMD Valuation Measures
| Enterprise Value | 47.02M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.0152907 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
MyMD Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 4.470652 |
| 52-Week Change | -29.0043% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.15 USD |
| 52 Week Low | 0.9 USD |
| 50-Day Moving Average | 1.78 USD |
| 200-Day Moving Average | 2.05 USD |
MYMD Share Statistics
| Avg. Volume (3 month) | 533.78K USD |
| Avg. Daily Volume (10-Days) | 406.48K USD |
| Shares Outstanding | 39.61M |
| Float | 32.32M |
| Short Ratio | 6.78 |
| % Held by Insiders | 17.83% |
| % Held by Institutions | 10.62% |
| Shares Short | 3.56M |
| Short % of Float | 9.93% |
| Short % of Shares Outstanding | 8.97% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.077% |
| Return on Equity (ttm) | -74.85% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -12745368 USD |
| Diluted EPS (ttm) | -0.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.55M USD |
| Total Cash Per Share (mrq) | 0.39 USD |
| Total Debt (mrq) | 126.03K USD |
| Total Debt/Equity (mrq) | 0.9 USD |
| Current Ratio (mrq) | 10.019 |
| Book Value Per Share (mrq) | 0.327 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13875528 USD |
| Levered Free Cash Flow (ttm) | -8165103 USD |
Profile of MyMD Pharmaceuticals
| Country | United States |
| State | MD |
| City | Baltimore |
| Address | 855 North Wolfe Street |
| ZIP | 21205 |
| Phone | (856) 848-8698 |
| Website | https://www.mymd.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic analog of cannabidiol for treating epilepsy, pain, and anxiety/depression. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
Q&A For MyMD Pharmaceuticals Stock
What is a current MYMD stock price?
MyMD Pharmaceuticals MYMD stock price today per share is 2.4 USD.
How to purchase MyMD Pharmaceuticals stock?
You can buy MYMD shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MyMD Pharmaceuticals?
The stock symbol or ticker of MyMD Pharmaceuticals is MYMD.
Which industry does the MyMD Pharmaceuticals company belong to?
The MyMD Pharmaceuticals industry is Biotechnology.
How many shares does MyMD Pharmaceuticals have in circulation?
The max supply of MyMD Pharmaceuticals shares is 2.16M.
What is MyMD Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
MyMD Pharmaceuticals PE Ratio is now.
What was MyMD Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
MyMD Pharmaceuticals EPS is -5.33 USD over the trailing 12 months.
Which sector does the MyMD Pharmaceuticals company belong to?
The MyMD Pharmaceuticals sector is Healthcare.
MyMD Pharmaceuticals MYMD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Nasdaq CRB Monitor Global Canna HERBAL | 203.61 USD — |
-3.73
|
— — | 203.61 USD — | 203.61 USD — | — - | — — |
| Nasdaq CRB Monitor Global Canna HERBALAUNR | 239.99 AUD 158.84 USD |
-3.25
|
— — | 239.8 AUD 158.72 USD | 240.17 AUD 158.96 USD | — - | — — |
- {{ link.label }} {{link}}